Fig. 2

(A) Immunofluorescence representative images and relative quantification for the marker PPAR β/δ (in green) in control and treated cells. (In blue DAPI). Scale bar: 50 μm. (B) WB and relative densitometric analysis for cytoplasmic and nuclear PPAR β/δ in control and treated cells. (C) WB and relative densitometric analysis for control and treated cells for 4-HNE proteins adducts. (D) Oxyblot representative image of the membrane and relative densitometric analysis. (E) ROS level evaluation (DCFDA assay) in control and treated cells. (F) SOD activity in control and treated cells. *** p < 0.0005; ** p < 0.005; * p < 0.05 vs. control (CTR). ⁺⁺⁺p < 0.0005; ++p < 0.005; +p < 0.05 vs. 6-OHDA (n = 3)